Predictive value of myeloperoxidase to identify high risk patients admitted to the hospital with acute chest pain;Valor preditivo da mieloperoxidase na identificação de pacientes de alto risco admitidos por dor torácica aguda

Arquivos Brasileiros de Cardiologia

Volumn 89, Issue 6, 2007, Pages

  Esporcatte, Roberto ^a,b   Rey, Helena Cramer Veiga ^a   Rangel, Fernando Oswaldo Dias ^a   Rocha, Ricardo Mourilhe ^a   De Mendonça Filho, Hugo Tannus Furtado ^a   Dohmann, Hans Fernando Rocha ^a   Albanesi Filho, Francisco Manes ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Chest pain diagnosis; Coronary disease blood; Inflammation mediators; Peroxidases diagnostic use

Indexed keywords

MYELOPEROXIDASE; BIOLOGICAL MARKER; CREATINE KINASE MB; PEROXIDASE; TROPONIN I;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CONFIDENCE INTERVAL; DISEASE COURSE; ELECTROCARDIOGRAPHY; ENZYME BLOOD LEVEL; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION; THORAX PAIN; BLOOD; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; EPIDEMIOLOGY; HOSPITALIZATION; MIDDLE AGED;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; CHEST PAIN; CLINICAL ENZYME TESTS; CREATINE KINASE, MB FORM; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGIC METHODS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PEROXIDASE; TROPONIN I;

EID: 41149098078     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2007001800005     Document Type: Article

References (33)

1. Gibler WB, Runyon JP, Levy RC, Sayre MR, Kacich R, Hattemer CR, et al. A rapid diagnostic and treatment center for patients with chest pain in the emergency department. Ann Emerg Med. 1995;25:1-8.
2. Pope JH, Aufderheide TP, Ruthazer R, Woolard RH, Feldman JA, Beshansky JR, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med. 2000;342:1163-70.
3. Sociedade Brasileira de Cardiologia. I Diretriz de dor torácica na sala de emergência. Arq Bras Cardiol. 2002; 79 (supl 2): 1-22.
4. Blomkalns AL, Gibler WB. Development of the chest pain center: rationale, implementation, efficacy, and cost-effectiveness. Prog Cardiovasc Dis. 2004;46:393-403.
5. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-26.
6. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-43.
7. Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med. 2002;347:5-12.
8. Hazell LJ, Stocker R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem J. 1993;290:165-72.
9. Podrez EA, Schmitt D, Hoff HF, Hazen SL. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J Clin Invest. 1999;103:1547-60.
10. Hazen SL. Myeloperoxidase and plaque vulnerability. Arterioscler Thromb Vasc Biol. 2004;24:1143-6.
11. Eiserich JP, Baldus, S, Brennan ML, Ma W, Zhang C, Tousson A, et al. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science. 2002;296:2391-4.
12. Meuwese MC, Stroes ESG, Hazen SL, van Miert JN, Kuivenhoven JA, Schaub RG, et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals. The EPIC-Norfolk prospective population study. J Am Coll Cardiol. 2007;50:159-65.
13. Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce GL, Penn MS, et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA. 2001;286:2136-42.
14. Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Münzel T, et al, on behalf of the CAPTURE Investigators. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation. 2003;108:1440-5.
15. Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med. 2003;349:1595-604.
16. Tang WH, Tong W, Troughton RW, Martin MG, Shrestha K, Borowski A, et al. Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure. J Am Coll Cardiol. 2007;49:2364-70.
17. Daugherty A, Dunn JL, Rateri DL, Heinecke JW. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest. 1994;94:437-44.
18. Malle E, Hazell L, Stocker R, Sattler W, Esterbauer H, Waeg G. Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies. Arterioscler Thromb Vasc Biol. 1995;15, 982-9.
19. Hazell LJ, Arnold L, Flowers D, Waeg G, Malle E, Stocker, R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest. 1996;97:1535-44.
20. Malle E, Waeg G, Schreiber R, Grone EF, Sattler W, Grone HJ. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur J Biochem. 2000;267:4495-503.
21. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol. 2001;158:879-91.
22. Fu X, Kassim SY, Parks WC, Heinecke JW. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (matrix metalloproteinase (MMP)-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem. 2001;276:41279-87.
23. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284:835-42.
24. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al, for the Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163:2345-53.
25. Boersma E, Pieper KS, Steyerberg EW, Wilcox RG, Chang WC, Lee KL, et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation. 2000;101:2557-67.
26. Morrow D, Braunwald E. Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy. Circulation. 2003;108:250-2.
27. Westerhout CM, Fu Y, Lauer MS, James S, Armstrong PW, Al-Hattab E, et al., for the GUSTO-IV ACS Trial Investigators. Short and long term risk stratification in acute coronary syndrome. The added value of quantitative ST segment depression and multiple biomarkers. J Am Coll Cardiol. 2006;48:939-47.
28. Blankenberg S, Schnabel R, Lowenstein CJ, Caidahl K, Muenzel TF, Lubos E, et al. Diagnostic value of multimarker testing including myeloperoxidase in patients with acute coronary syndrome. Results from a Multicentre Biomarker Study. Abstract. Circulation. 2006; 114 (18 Suppl II): II-418.
29. Mocatta TJ, Pilbrow AP, Cameron VA, Senthilohan R, Frampton CM, Richards AM, et al . Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol. 2007;49:1993-2000.
30. Lu G, Kubala L, Berglund L, Eiserich JP. Plasma myeloperoxidase levels do not predict risk in patients with stable coronary artery disease. Abstract. Arterioscler Thromb Vasc Biol. 2005; 25: e96.
31. Reynolds WF, Chang E, Douer D, Ball ED, Kanda V. An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia. Blood. 1997;90:2730-7.
32. Kutter D, Devaquet P, Vanderstocken G, Paulus JM, Marchal V, Gothot A. Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit? Acta Haematol. 2000;104:10-5.
33. Asselbergs FW, Cohen-Tervaert. JW, Tio RA. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med. 2004;350:516-8.